SPYRE THERAPEUTICS INC
SYRENASDAQ🏆 #814 by market capEarnings Nov 2US Equity
$102.74▼ $2.53 (−2.46%)
🌅 Pre-market$103.01▲ 0.26%Regular close · extended-hours price shown1h—
24h▼ 2.5%
7d▼ 1.6%
14d▲ 5.0%
30d▲ 9.7%
1y▲ 545.8%
🏦Market Cap
$8.92B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
7550.7x
Expensive
Otter Score
61
Fair
Earnings
Q2 · 2026After-MarketReported 2026-08-04Earnings Per Share
Actual
-0.36
Expected
-0.77
beat
+53.50%
Revenue
Actual
$0.00
Expected
$0.00
inline
—
Consensus estimates